Discover the full directors' dealings record of LSL Pharma Group Inc., a listed equity based in Canada. Shares trade on CA CA, under the oversight of SEDI. Operating in the Health Care sector, LSL Pharma Group Inc. has logged 1 insider filings. Market capitalisation: €41.8m. The latest transaction was filed on 28 May 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Dugal, Alain. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal. See the method
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration